批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/04/17 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/01/20 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/01/20 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/12/21 |
SUPPL-11(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2006/07/11 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/10/22 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:CLINDAMYCIN PHOSPHATE 剂型/给药途径:AEROSOL, FOAM;TOPICAL 规格:1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050801 |
001 |
NDA |
EVOCLIN |
CLINDAMYCIN PHOSPHATE |
AEROSOL, FOAM;TOPICAL |
1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AT |
2004/10/22
|
NORVIUM BIOSCIENCE |